Suppr超能文献

重新思考肾移植中的不相容性。

Rethinking incompatibility in kidney transplantation.

机构信息

Department of Surgery, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.

出版信息

Am J Transplant. 2022 Apr;22(4):1031-1036. doi: 10.1111/ajt.16826. Epub 2021 Sep 15.

Abstract

Donor/recipient incompatibility in kidney transplantation classically refers to ABO/HLA-incompatibility. Kidney paired donation (KPD) was historically established to circumvent ABO/HLA-incompatibility, with the goal of identifying ABO/HLA-compatible matches. However, there is a broad range of donor factors known to impact recipient outcomes beyond ABO/HLA-incompatibility, such as age and weight, and quantitative tools are now available to empirically compare potential living donors across many of these factors, such as the living donor kidney donor profile index (LKDPI). Moreover, the detrimental impact of mismatch at other HLA antigens (such as DQ) and epitope mismatching on posttransplant outcomes has become increasingly recognized. Thus, it is time for a new paradigm of incompatibility that considers all of these risks factors together in assessing donor/recipient compatibility and the potential utility for KPD. Under this new paradigm of incompatibility, we show how the LKDPI and other tools can be used to identify donor/recipient incompatibilities that could be improved through KPD, even for those with a traditionally "compatible" living donor.

摘要

在肾移植中,供受者不相容性通常是指 ABO/HLA 不相容。肾配对供体(KPD)的历史建立是为了规避 ABO/HLA 不相容,其目的是确定 ABO/HLA 相容的匹配。然而,除了 ABO/HLA 不相容之外,还有许多已知的供体因素会影响受者的结局,例如年龄和体重,并且现在有定量工具可用于根据许多这些因素对潜在的活体供体进行经验比较,例如活体供体肾脏供体概况指数(LKDPI)。此外,其他 HLA 抗原(如 DQ)和表位错配的不匹配对移植后结局的不良影响也越来越受到关注。因此,现在是时候建立一个新的不相容性范式,该范式将所有这些风险因素一起考虑,以评估供受者的相容性和 KPD 的潜在效用。在这种新的不相容性范式下,我们展示了 LKDPI 和其他工具如何用于识别可以通过 KPD 改善的供受者不相容性,即使对于那些传统上“相容”的活体供体也是如此。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验